These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1305562)

  • 1. [Evaluation of an immunoenzymatic assay for determining estrogen and progesterone receptors in breast tumors].
    Kopczyński Z; Stachowicz A; Kociałkowski K; Grodecka-Gazdecka S; Faryńska E
    Ginekol Pol; 1992; 63(10):528-33. PubMed ID: 1305562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of mucin-like associated antigen (MCA) in neoplasms of the mammary gland].
    Kopczyński Z; Stachowicz A; Kociałkowski K; Grodecka-Gazdecka S
    Ginekol Pol; 1993 Feb; 64(2):87-92. PubMed ID: 8359732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Receptor (ER, PgR) levels as prognostic factors in the endocrine therapy of pre- and post-menopausal patients with stage III infiltrative ductal and lobular cancer of the breast].
    Calzada L; Salazar EL; Pedron Nuevo N
    Ginecol Obstet Mex; 1996 Mar; 64():135-9. PubMed ID: 8729191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and progesterone receptors in human breast cancer. Correlation with histologic subtype and degree of differentiation.
    Mohammed RH; Lakatua DJ; Haus E; Yasmineh WJ
    Cancer; 1986 Sep; 58(5):1076-81. PubMed ID: 3015374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of estrogen and progesterone receptors in human breast cancer cytosols: a comparison between radioligand binding assay (DCC) and enzyme immunoassay (EIA).
    Cerra M; Cecco L; Montella M; Celentano E; Bonelli P; Tuccillo F
    Int J Biol Markers; 1996; 11(1):50-2. PubMed ID: 8740643
    [No Abstract]   [Full Text] [Related]  

  • 6. [Valoration of the epidermal growth factor receptor (EGFR) in benign breast disease and its relation with expression in malignant tumors classified by hormonal dependence].
    Allende MT; Raigoso PF; Alvarez A; Llana B; Sánchez A; Martínez MI; Miralles MT; Roiz C
    Rev Esp Med Nucl; 1999; 18(1):32-6. PubMed ID: 10074215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical evaluation of nuclear estrogen receptors combined with cytosolic estrogen and progesterone receptors in breast cancer.
    Loven D; Rakowsky E; Geier A; Lunenfeld B; Rubinstein A; Klein B; Lurie H
    Cancer; 1990 Jul; 66(2):341-6. PubMed ID: 2369715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of estrogen and progesterone receptor and neu expression in breast carcinoma.
    Chu JS; Lee WJ; Chen KM; Hsu HC
    J Formos Med Assoc; 1994 Apr; 93(4):277-82. PubMed ID: 7914767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of estrogen and progesterone receptors enzyme immunoassay in malignant, benign and surrounding normal thyroid tissue.
    Bonacci R; Pinchera A; Fierabracci P; Gigliotti A; Grasso L; Giani C
    J Endocrinol Invest; 1996 Mar; 19(3):159-64. PubMed ID: 8743281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative measurement of estrogen and progesterone receptors in breast lumps using image cytometry.
    Sarker SK; Mendiola R; Walker M; Coleman DV
    Anal Quant Cytol Histol; 1997 Feb; 19(1):87-91. PubMed ID: 9051191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the expression on the CD44v5 adhesion molecule in invasive lobular carcinomas of the breast. Association between negativity and cellular S-phase fraction >7%.
    Ruibal A; Arias J; Del Rio MC; Schneider J; Tejerina A
    Int J Biol Markers; 2000; 15(2):195-6. PubMed ID: 10883896
    [No Abstract]   [Full Text] [Related]  

  • 12. FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
    Buck A; Schirrmeister H; Kühn T; Shen C; Kalker T; Kotzerke J; Dankerl A; Glatting G; Reske S; Mattfeldt T
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1317-23. PubMed ID: 12271413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptors for estrogen and progesterone in breast carcinoma in situ.
    Pallis L; Wilking N; Cedermark B; Rutqvist LE; Skoog L
    Anticancer Res; 1992; 12(6B):2113-5. PubMed ID: 1295456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between alcohol consumption and risk of different types of breast cancer].
    Berdoz D; Ellison RC
    Rev Med Suisse; 2015 Sep; 11(485):1677. PubMed ID: 26541003
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of steroid hormone receptors with respect to tumor cellularity.
    Geppert M; Smyczek-Gargya B; Dietl J; Schneider H
    Zentralbl Pathol; 1993 Aug; 139(3):217-9. PubMed ID: 8218122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of oestrogen receptor-beta in invasive breast tumours].
    Péter I; Számel I; Péley G
    Magy Onkol; 2004; 48(1):63-9. PubMed ID: 15105898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological quantitation of nuclear receptors in human breast cancer: relation to cytosolic estrogen and progesterone receptors.
    Thorpe SM
    Cancer Res; 1987 Apr; 47(7):1830-5. PubMed ID: 3545455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric steroid receptor analysis.
    Schutte B; Scheres HM; De Goeij AF; Rousch MJ; Blijham GH; Bosman FT; Ramaekers FC
    Prog Histochem Cytochem; 1992; 26(1-4):68-76. PubMed ID: 1484969
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohistochemical analysis of estrogen and progesterone receptors in benign breast diseases.
    Tóth J; De Sombre ER; Greene GL
    Zentralbl Pathol; 1991; 137(3):227-32. PubMed ID: 1931896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significances of estrogen and progesterone receptors in primary operable breast cancer.
    Kurebayashi J; Ishida T; Higashi Y; Suemasu K; Nomoto C; Yoshida K
    Jpn J Clin Oncol; 1990 Sep; 20(3):271-80. PubMed ID: 2255103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.